Frontiers in Immunology (Feb 2020)

Preferential HLA-B27 Allorecognition Displayed by Multiple Cross-Reactive Antiviral CD8+ T Cell Receptors

  • Louise C. Rowntree,
  • Louise C. Rowntree,
  • Louise C. Rowntree,
  • Heleen van den Heuvel,
  • Heleen van den Heuvel,
  • Jessica Sun,
  • Lloyd J. D'Orsogna,
  • Lloyd J. D'Orsogna,
  • Thi H. O. Nguyen,
  • Frans H. J. Claas,
  • Jamie Rossjohn,
  • Jamie Rossjohn,
  • Jamie Rossjohn,
  • Tom C. Kotsimbos,
  • Tom C. Kotsimbos,
  • Anthony W. Purcell,
  • Nicole A. Mifsud,
  • Nicole A. Mifsud,
  • Nicole A. Mifsud

DOI
https://doi.org/10.3389/fimmu.2020.00248
Journal volume & issue
Vol. 11

Abstract

Read online

T cells provide essential immunosurveillance to combat and eliminate infection from pathogens, yet these cells can also induce unwanted immune responses via T cell receptor (TCR) cross-reactivity, also known as heterologous immunity. Indeed, pathogen-induced TCR cross-reactivity has shown to be a common, robust, and functionally potent mechanism that can trigger a spectrum of human immunopathologies associated with either transplant rejection, drug allergy, and autoimmunity. Here, we report that several virus-specific CD8+ T cells directed against peptides derived from chronic viruses (EBV, CMV, and HIV-1) presented by high frequency HLA-A and -B allomorphs differentially cross-react toward HLA-B27 allotypes in a highly focused and hierarchical manner. Given the commonality of cross-reactive T cells and their potential contribution to adverse outcomes in allogeneic transplants, our study demonstrates that multiple antiviral T cells recognizing the same HLA allomorph could pose an extra layer of complexity for organ matching.

Keywords